HomeMBio Diagnostics Inc.

MBio Diagnostics Inc.

MBio is Seeking FDA Approval for LightDeck® Platform

The expanded scope contract is with the US Defense Advanced Research Projects Agency (DARPA), where DARPA will apply additional resources and funds to accelerate progress towards FDA approval for MBio's LightDeck® platform.

Two Contracts for Sepsis Test Development Announces MBio Diagnostics

MBio’s HJF contract is in collaboration with the Austere environments Consortium for Enhanced Sepsis Outcomes